Article
Transgenic overexpression of ribonucleotide reductase improves cardiac performance.
Proceedings of the National Academy of Sciences of the United States of America - 9 Apr 2013
Nowakowski Sarah G, Kolwicz Stephen C, Korte Frederick Steven, Luo Zhaoxiong, Robinson-Hamm Jacqueline N, Page Jennifer L, Brozovich Frank, Weiss Robert S, Tian Rong, Murry Charles E, Regnier Michael
Abstract excerpt
We previously demonstrated that cardiac myosin can use 2-deoxy-ATP (dATP) as an energy substrate, that it enhances contraction and relaxation with minimal effect on calcium-handling properties in vitro, and that contractile enhancement occurs with only minor elevation of cellular [dATP]. Here, we report the effect of chronically enhanced dATP concentration on cardiac function using a transgenic mouse that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
